Akari Therapeutics to present PH1 ADC payload platform at oncology and investor conferences
AKTX•Upcoming conference presentations and investor meetings
- Akari will present its PH1 ADC payload platform at conferences in September 2026 across the U.S. and China.
- CEO Abizer Gaslightwala speaks at the Oncology & Immunology Innovation Partnering & Licensing Summit in Boston on Sept. 9-10.
- Management joins the H.C. Wainwright Global Investment Conference in New York on Sept. 14-16.
- Gaslightwala delivers a keynote at BioCon China in Shanghai on Sept. 15-16.
- Akari also presents at the Global XDC Innovation Conference in WuXi on Sept. 17-19, then holds investor meetings at ROTH’s conference in New York on Sept. 29.
